Completed NA INTERVENTIONAL 2-arm NCT01258335

Omega-3-fatty Acids on Age-related Macular (Omega 3)

Short Term Ocular Safety Assessment of High Dose Omega-3 Supplementation for Age-Related Macular Degeneration.

Sponsor: LifeGuard

Updated 6 times since 2017 Last updated: Nov 21, 2011 Started: Oct 31, 2008 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Aged Macular Degeneration and is currently completed. LifeGuard leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LifeGuard
Mid Atlantic Retina

Data source: Mid Atlantic Retina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States